Protein kinase C in porcine retinal arteries and neuroretina following retinal ischemia-reperfusion

Molecular Vision

Volumn 15, Issue , 2009, Pages 737-746

  Gesslein, Bodil ^a   Gustafsson, Lotta ^a   Wackenfors, Angelica ^a   Ghosh, Fredrik ^a   Malmsjö, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; ELONGATION FACTOR 1ALPHA; MESSENGER RNA; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C BETA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINA ARTERY; RETINA BIPOLAR GANGLION CELL; RETINA BLOOD VESSEL; RETINA ISCHEMIA; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; REPERFUSION INJURY; RETINA; RETINAL ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUS SCROFA;

EID: 65349124254     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23:91-147.
2. Dorrell M, Uusitalo-Jarvinen H, Aguilar E, Friedlander M. Ocular neovascularization: basic mechanisms and therapeutic advances. Surv Ophthalmol 2007; 52:S3-19.
3. Curtis TM, Scholfield CN. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev 2004; 20:28-43.
4. Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2004; 15:508-18.
5. Hessellund A, Jeppesen P, Aalkjaer C, Bek T. Characterization of vasomotion in porcine retinal arterioles. Acta Ophthalmol Scand 2003; 81:278-82.
6. Holmgaard K, Aalkjaer C, Lambert JD, Bek T. N-methyl-D-aspartic acid causes relaxation of porcine retinal arterioles through an adenosine receptor-dependent mechanism. Invest Ophthalmol Vis Sci 2008; 49:4590-4.
7. Nagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest Ophthalmol Vis Sci 2007; 48:4232-9.
8. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 2005; 36:2781-90.
9. Chou WH, Messing RO. Protein kinase C isozymes in stroke. Trends Cardiovasc Med 2005; 15:47-51.
10. Armstrong SC. Protein kinase activation and myocardial ischemia/ reperfusion injury. Cardiovasc Res 2004; 61:427-36.
11. Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 1999; 99:384-91.
12. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J Cereb Blood Flow Metab 2007; 27:21-32.
13. Henriksson M, Stenman E, Vikman P, Edvinsson L. Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. BMC Neurosci 2007; 8:7.
14. Nilsson D, Wackenfors A, Gustafsson L, Ugander M, Ingemansson R, Edvinsson L, Malmsjö M. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression. Eur J Pharmacol 2008; 580:190-200.
15. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 2002; 47:S263-9.
16. Danis RP, Bingaman DP, Jirousek M, Yang Y. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. Invest Ophthalmol Vis Sci 1998; 39:171-9.
17. Cardell M, Wieloch T. Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat. J Neurochem 1993; 61:1308-14.
18. Cardell M, Bingren H, Wieloch T, Zivin J, Saitoh T. Protein kinase C is translocated to cell membranes during cerebral ischemia. Neurosci Lett 1990; 119:228-32.
19. Louis JC, Magal E, Brixi A, Steinberg R, Yavin E, Vincendon G. Reduction of protein kinase C activity in the adult rat brain following transient forebrain ischemia. Brain Res 1991; 541:171-4.
20. Osborne NN. Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia. Vis Neurosci 1999; 16:45-52.
21. Osborne NN, Wood J, Muller A. The influence of experimental ischaemia on protein kinase C and the GABAergic system in the rabbit retina. Neuropharmacology 1995; 34:1279-88.
22. Barnett NL, Osborne NN. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp Eye Res 1995; 61:83-90.
23. Osborne NN, Broyden NJ, Barnett NL, Morris NJ. Protein kinase C (alpha and beta) immunoreactivity in rabbit and rat retina: effect of phorbol esters and transmitter agonists on immunoreactivity and the translocation of the enzyme from cytosolic to membrane compartments. J Neurochem 1991; 57:594-604.
24. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-93.
25. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99:3-8.
26. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007; 55:498-510.
27. Obara K, Hata S, Sato K, Koide M, Ishii K, Nakayama K. Contractile potentiation by endothelin-1 involves protein kinase C-delta activity in the porcine coronary artery. Jpn J Physiol 1999; 49:175-83.
28. Wood JP, McCord RJ, Osborne NN. Retinal protein kinase C. Neurochem Int 1997; 30:119-36.
29. Harada K, Maekawa T, Abu Shama KM, Yamashima T, Yoshida K. Translocation and down-regulation of protein kinase C-alpha, -beta, and -gamma isoforms during ischemia-reperfusion in rat brain. J Neurochem 1999; 72:2556-64.
30. PKC-DMES Study Group. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol 2007; 125:318-24.
31. Aiello LP, Clermont A, Arora V, Davis MD, Sheetz MJ, Bursell SE. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. Invest Ophthalmol Vis Sci 2006; 47:86-92.
32. Siliprandi R, Bucci MG, Canella R, Carmignoto G. Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cats. Invest Ophthalmol Vis Sci 1988; 29:558-65.
33. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 1993; 34:3232-45.
34. la Cour M, Kiilgaard JF, Eysteinsson T, Wiencke AK, Bang K, Dollerup J, Jensen PK, Stefánsson E. Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. Br J Ophthalmol 2000; 84:1045-9.
35. Zheng L, Szabo C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004; 53:2960-7.